These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 213704)

  • 1. Rat mast cell high affinity cyclic nucleotide phosphodiesterases: separation and inhibitory effects of two antiallergic agents.
    Bergstrand H; Lundquist B; Schurmann A
    Mol Pharmacol; 1978 Sep; 14(5):848-55. PubMed ID: 213704
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effects of cromoglycate and theophylline on rat macrophage and mast-cell cyclic nucleotide phosphodiesterase [proceedings].
    Saeed SA; Butt NM; Sheldon D; Taylor WA
    Biochem Soc Trans; 1979 Dec; 7(6):1304-6. PubMed ID: 231532
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases.
    Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A
    Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182
    [No Abstract]   [Full Text] [Related]  

  • 4. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the inhibitory effects of cromoglycate on cyclic nucleotide phosphodiesterase activity in intact lymphocytes, macrophages and mast cells [proceedings].
    Saeed SA; Butt NM; Sheldon D; Edwards DJ; Taylor WA
    Biochem Soc Trans; 1980 Apr; 8(2):199-200. PubMed ID: 6245975
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
    Yanagihara Y; Abe T; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):75-9. PubMed ID: 2452639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.
    Frossard N; Landry Y; Pauli G; Ruckstuhl M
    Br J Pharmacol; 1981 Aug; 73(4):933-8. PubMed ID: 6168323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of a low Km phosphodiesterase from liver by insulin and glucagon.
    Loten EG; Assimacopoulos-Jeannet FD; Exton JH; Park CR
    J Biol Chem; 1978 Feb; 253(3):746-57. PubMed ID: 202597
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased levels of cyclic adenosine monophosphate contribute to the hyporesponsiveness of mast cells in alloxan diabetes.
    Barreto EO; Carvalho VF; Lagente V; Lugnier C; Cordeiro RS; Martins MA; E Silva PM
    Int Immunopharmacol; 2004 Jun; 4(6):755-62. PubMed ID: 15135317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current views of the mechanism of action of prophylactic antiallergic drugs.
    González Alvarez R; Arruzazabala ML
    Allergol Immunopathol (Madr); 1981; 9(6):501-8. PubMed ID: 6122370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the inhibition of phosphodiesterase activity and allergic histamine release by disodium cromoglycate and compound I.C.I. 74917.
    Barrett-Bee K; Henderson W
    Biochem Soc Trans; 1976; 4(4):699-701. PubMed ID: 63402
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic nucleotide phosphodiesterases of human and rat gastric mucosa.
    Klotz U; Antonin KH; Bieck P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):187-90. PubMed ID: 189231
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical properties of high-affinity cyclic AMP phosphodiesterases.
    Thompson WJ; Pratt ML; Strada SJ
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():137-48. PubMed ID: 6326519
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of cyclic nucleotide phosphodiesterases with multiple separation techniques.
    Van Inwegen RG; Pledger WJ; Strada SJ; Thompson WJ
    Arch Biochem Biophys; 1976 Aug; 175(2):700-9. PubMed ID: 183123
    [No Abstract]   [Full Text] [Related]  

  • 16. Calmodulin-dependent cyclic AMP phosphodiesterase in liver plasma membranes: stimulated by insulin.
    Smoake JA; Moy GM; Fang B; Solomon SS
    Arch Biochem Biophys; 1995 Nov; 323(2):223-32. PubMed ID: 7487081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of compound 48/80 on mast cells, histamine, and cyclic AMP in isolated superior cervical ganglia.
    Lindl T; Behrendt H; Heinl-Sawaja MC; Teufel E; Cramer H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(3):283-96. PubMed ID: 4142070
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mast cell degranulation-induced drop of blood pressure with clemastine, cromolyn and compound 48/80 pretreatment.
    Peternel L; Cerne M; Drevensek G; Stempelj M; Urleb U; Stanovnik L; Budihna MV
    Inflamm Res; 2006 Apr; 55 Suppl 1():S07-8. PubMed ID: 16705372
    [No Abstract]   [Full Text] [Related]  

  • 20. Brain low-Km cAMP phosphodiesterase.
    de Mazancourt P; Giudicelli Y
    Methods Enzymol; 1988; 159():766-72. PubMed ID: 2842640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.